Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Schering AG describes new progestogenic steroids

Sep. 8, 1998

Novel actions of statins reported at the 20th Congress of the European Society of Cardiology

Sep. 8, 1998

Bayer, Fournier to copromote statin in some EU countries

Sep. 7, 1998

Oral osteoporosis product developed by Lilly and Emisphere heads for clinical trials

Sep. 7, 1998

Efficacy and safety of sublingual apomorphine in treatment of MED

Sep. 7, 1998

Invicorp trial results highlighted at recent congress

Sep. 7, 1998

First small-molecule G-CSF mimic synthesized by SB-Ligand team

Sep. 7, 1998

LLPGE1 evaluated in pilot study; findings will be applied to future studies

Sep. 4, 1998

Alprostadil alfadex is a promising treatment for ED

Sep. 4, 1998

Merck KGaA synthesizes new PDE V inhibitor with potential for treating ED

Sep. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...